Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
14.08
+0.16 (1.15%)
Mar 4, 2026, 4:00 PM EST - Market closed
Surgery Partners Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Surgery Partners stock have an average target of 25.13, with a low estimate of 14 and a high estimate of 36. The average target predicts an increase of 78.48% from the current stock price of 14.08.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Surgery Partners stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Hold | 4 | 3 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $31 → $20 | Buy | Maintains | $31 → $20 | +42.05% | Mar 4, 2026 |
| Barclays | Barclays | Hold Maintains $18 → $14 | Hold | Maintains | $18 → $14 | -0.57% | Mar 3, 2026 |
| Mizuho | Mizuho | Buy Maintains $22 → $19 | Buy | Maintains | $22 → $19 | +34.94% | Dec 18, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $27 → $20 | Hold | Maintains | $27 → $20 | +42.05% | Nov 24, 2025 |
| Barclays | Barclays | Hold Maintains $24 → $18 | Hold | Maintains | $24 → $18 | +27.84% | Nov 21, 2025 |
Financial Forecast
Revenue This Year
3.63B
from 3.31B
Increased by 9.71%
Revenue Next Year
3.91B
from 3.63B
Increased by 7.82%
EPS This Year
0.75
from -0.61
EPS Next Year
0.97
from 0.75
Increased by 28.91%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 3.9B | 4.2B | ||
| Avg | 3.6B | 3.9B | ||
| Low | 3.4B | 3.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 16.6% | 16.7% | ||
| Avg | 9.7% | 7.8% | ||
| Low | 1.3% | -2.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 0.97 | 1.33 | ||
| Avg | 0.75 | 0.97 | ||
| Low | 0.28 | 0.48 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | - | 77.9% | ||
| Avg | - | 28.9% | ||
| Low | - | -35.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.